We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cardiol Therapeutics Inc | TSX:CRDL | Toronto | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.31 | -9.45% | 2.97 | 2.96 | 2.99 | 3.46 | 2.96 | 3.40 | 252,477 | 19:45:52 |
From Jun 2019 to Jun 2024
OAKVILLE, Ontario, June 3, 2019 /PRNewswire/ -- Cardiol Therapeutics Inc. (TSX: CRDL; OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for inflammatory diseases, announces that David Elsley, President and CEO of Cardiol, will present live at VirtualInvestorConferences.com on June 4th.
DATE: Tuesday, June 4th
TIME: 9:30 AM EST
LINK: https://tinyurl.com/June4CannabisVIC
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
About Virtual Investor Conferences
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors. A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
About Cardiol Therapeutics
Cardiol Therapeutics Inc. is a leader in the research and commercial development of pharmaceutical CBD products and targeted therapies for inflammatory disease. The Company is leveraging its expertise in pharmaceutical CBD to develop ultra-pure CBD products for commercialization in the billion dollar market for medicinal cannabinoids in Canada, with a view to expanding into Latin America and Europe, and utilizing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure. Heart failure is a leading cause of death and hospitalization, with associated healthcare costs exceeding $30 billion annually in the U.S. alone. For further information about Cardiol, please visit the Company's website at www.cardiolrx.com.
View original content:http://www.prnewswire.com/news-releases/cardiol-therapeutics-to-webcast-live-at-virtualinvestorconferencescom-on-june-4th-300860950.html
SOURCE VirtualInvestorConferences.com
Copyright 2019 PR Newswire
1 Year Cardiol Therapeutics Chart |
1 Month Cardiol Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
